1[2]Hennesy C,Henry JA,May FE,et al.Expression of the antimetastatic gene nm 23 in human breast cancer;An association with good prognosis.J Natl Cancer lust,1991,83:281-285.
3[4]Agou F,Ravch S.Single strand DNA specificity analysis of human aucleoside B.J Biol Chem,1999,274:19630-19638.
4[5]Dabernat S,1arou M.Organization and expression of mouse nm 23-H1 gene comparison woth nm 23-H2 express.Gene,1999,236:221-223.
5[6]Wagner DD,Wu ND.Histidine to aspartate hposphotrans ferase activity Of nm 23 proteinsi:phosphorylation of aldolase C on asp-319.Biochem J,2000,346:623-630.
5Takeichi M.Cadherin incancer:implication for invasive and metastasis[J].Curr Opin Oncol,1993;5:806.
6Kaufmann M,Heider KH,Sinn HP.CD44 variant exon epitopes in primary breast cancerand length of survival[J].The Lancet,1995;11:345(8950):615-619.
7Firechriches K,Franke F,Lisboa Bw.CD44 isoforms correlate with cellulardifferentiation but not with prognosis in human breast cancer[J]. CancerRes,1995;55(22):5424-33.
8Dall P,Herder KH,sinn HP,et al.Comparison of immunohistochemistry and RT-PCR fordetection of CD44-expression:a new prognostic factor in human breast cancer[J].Int JCancer,1995;60:471.
9Roye GD,Myers RB,Brown D,et al.CD44 expression in dysplastic epithelium andsquamous cell carcinoma of the esophagus[J].Int J Cancer,1996;69:254.
10Rodrigaez c,Monges G.CD44 expression patterns in breast and colon tumors:aPCR-based study of splice variants[J].Int J Cancer,1995;20:64(5):347-54.
